A Clinical Trial for Treatment-Resistant Subtypes of Self Injury
A Clinical Trial for Treatment-Resistant Subtypes of Self Injury
批准号:
10206205
负责人:
LOUIS P. HAGOPIAN
金额:
$33.67万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-27 至 2024-11-30
关键词:
AddressAttentionBehaviorBehavior TherapyBiologicalBlindnessClinicalClinical TreatmentClinical TrialsCrossover DesignDataData AnalysesData SetDevicesEffectivenessEquipmentImpairmentIndividualInjuryInpatientsIntellectual functioning disabilityInterventionLawsLiteratureMethodsNational Institute of Child Health and Human DevelopmentPatientsPersonsPhasePositioning AttributeProceduresPsychological reinforcementRandomizedReinforcement ScheduleResearchResearch SupportResistanceSelf-Help DevicesSelf-Injurious BehaviorSelf-control as a personality traitSocial ReinforcementSourceStandardizationStimulusTestingToyTrainingbasedesigneffective interventionexperienceinsightloss of functionnovelprogramsreinforcerrestraintskillsstandard of caresuccess
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
At least one quarter of the 18 million persons in the US with intellectual and developmental disabilities engage
in self-injurious behavior (SIB), which can result in injuries, disfigurement, and loss of function (e.g., blindness).
In most cases, SIB is maintained by social reinforcement (e.g., attention). SIB that persists in the absence of
social reinforcement has been referred to as automatically reinforced SIB (ASIB), based on the supposition
that the behavior itself produces some type of biological reinforcement. The current standard of care approach
to treatment for ASIB includes two phases: a Pre-Treatment Assessment (a Competing Stimulus Assessment
to identify stimuli associated with reductions in ASIB), followed by treatment where competing stimuli are
delivered on a noncontingent reinforcement (NCR) schedule. Our NICHD- supported research to date has
identified subtypes of ASIB that vary greatly in terms of their responsiveness to these treatments. Subtypes are
based on results of standardized assessment conditions: Subtype 1 varies inversely with the level of
stimulation across conditions; Subtype 2 is invariant; and Subtype 3 is characterized by self-restraint, a
self-limiting behavior that occurs to avoid ASIB, but also impairs adaptive functioning. Treatments using NCR
with competing stimuli alone are effective in over 82% of cases with Subtype 1, but in only 7% of cases with
Subtype 2 or 3, necessitating restraint or protective equipment to sufficiently reduce ASIB. The identification of
subtypes has revealed the urgent need for more effective interventions for the treatment-resistant subtypes.
Fortunately, our research (R01 HD076653) has also led to several recent discoveries that provide the
conceptual and empirical basis for a new Intensified Approach to treatment targeting the most
treatment-resistant subtypes (Subtype 2 and 3 ASIB). The proposed treatment approach is based on the same
principles as the current Standard of Care Approach (Matching Law and reinforcer competition), but employs
novel methods to more effectively compete with reinforcement maintaining Subtype 2 and 3 ASIB, and to
address self-restraint for Subtype 3. The proposed Intensified Approach to treatment includes three phases: 1)
Pre-Treatment Assessments will identify competing stimuli, tasks, and self-control devices that reduce ASIB; 2)
Intensive Training to strengthen skills needed to fully access available reinforcement, and replace debilitating
self-restraint; and 3) Combination Treatment using NCR to deliver, and differential reinforcement for
engagement with: multiple competing stimuli, competing tasks, and alternative self-control devices (for Subtype
3). Combination Treatment is designed to greatly increase the amount and vary the sources of alternative
reinforcement. Aim 1 is to identify and establish competing stimuli, competing tasks, and self-control devices
(Subtype 3 ASIB). Aim 2 is to employ a randomized crossover design to demonstrate the effectiveness of
Combination Treatment (developed using the Intensified Approach), relative to NCR with competing stimuli
alone (developed using the current Standard of Care Approach) for reducing ASIB and self-restraint.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Delineating Subtypes of Self-Injurious Behavior Maintained by Automatic Reinforce
-
批准号:8862519
-
项目类别:
-
资助金额:$29.43万
-
财政年份:2013
-
负责人:LOUIS P. HAGOPIAN
-
依托单位:
Delineating Subtypes of Self-Injurious Behavior Maintained by Automatic Reinforce
-
批准号:9284283
-
项目类别:
-
资助金额:$30.18万
-
财政年份:2013
-
负责人:LOUIS P. HAGOPIAN
-
依托单位:
Delineating Subtypes of Self-Injurious Behavior Maintained by Automatic Reinforce
-
批准号:8630630
-
项目类别:
-
资助金额:$29.86万
-
财政年份:2013
-
负责人:LOUIS P. HAGOPIAN
-
依托单位:
Delineating Subtypes of Self-Injurious Behavior Maintained by Automatic Reinforce
-
批准号:8744304
-
项目类别:
-
资助金额:$29.34万
-
财政年份:2013
-
负责人:LOUIS P. HAGOPIAN
-
依托单位:
A Clinical Trial for Treatment-Resistant Subtypes of Self Injury
-
批准号:10407635
-
项目类别:
-
资助金额:$33.67万
-
财政年份:2013
-
负责人:LOUIS P. HAGOPIAN
-
依托单位:
Translational Analyses of Chronic Aberrant Behavior Across the Life Span
-
批准号:8512751
-
项目类别:
-
资助金额:$88.07万
-
财政年份:2009
-
负责人:LOUIS P. HAGOPIAN
-
依托单位:
AUTISM AND DIFFERENCES IN BEHAVIORAL CONTROL BY CONTINGENCIES OF POSITIVE REINEN
-
批准号:7604733
-
项目类别:
-
资助金额:$0.05万
-
财政年份:2006
-
负责人:LOUIS P. HAGOPIAN
-
依托单位:
AUTISM AND DIFFERENCES IN BEHAVIORAL CONTROL BY CONTINGENCIES OF POSITIVE REINEN
-
批准号:7378981
-
项目类别:
-
资助金额:$0.29万
-
财政年份:2005
-
负责人:LOUIS P. HAGOPIAN
-
依托单位:
Examining Contingency Control Deficits in Autism and MR
-
批准号:7081367
-
项目类别:
-
资助金额:$24.76万
-
财政年份:2004
-
负责人:LOUIS P. HAGOPIAN
-
依托单位:
Examining Contingency Control Deficits in Autism and MR
-
批准号:6898349
-
项目类别:
-
资助金额:$25.36万
-
财政年份:2004
-
负责人:LOUIS P. HAGOPIAN
-
依托单位:
Examining Contingency Control Deficits in Autism and MR
-
批准号:6826453
-
项目类别:
-
资助金额:$25.17万
-
财政年份:2004
-
负责人:LOUIS P. HAGOPIAN
-
依托单位:
国内基金
海外基金
多模态超声VisTran-Attention网络评估早期子宫颈癌保留生育功能手术可行性
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:郑巧
-
依托单位:
Ultrasomics-Attention孪生网络早期精准评估肝内胆管癌免疫治疗的研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:陈立达
-
依托单位: